Beyond the Development of Health-Related Quality-of-Life (HRQOL) Measures: A Checklist for Evaluating HRQOL Outcomes in Cancer Clinical Trials—Does HRQOL Evaluation in Prostate Cancer Research Inform Clinical Decision Making?
- 15 September 2003
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (18) , 3502-3511
- https://doi.org/10.1200/jco.2003.12.121
Abstract
Purpose: The aim of this study was to evaluate whether the inclusion of health-related quality of life (HRQOL), as a part of the trial design in a randomized controlled trial (RCT) setting, has supported clinical decision making for the planning of future medical treatments in prostate cancer.Keywords
This publication has 50 references indexed in Scilit:
- Health related quality of life in prostate carcinoma patientsCancer, 2003
- Quality of life in patients undergoing systemic therapy for advanced breast cancerThe Lancet Oncology, 2002
- Beyond the Development of Quality-of-Life Instruments: Where Do We Go From Here?Journal of Clinical Oncology, 2002
- Use of the CONSORT Statement and Quality of Reports of Randomized TrialsJAMA, 2001
- The standard of reporting of health-related quality of life in clinical cancer trialsJournal of Clinical Epidemiology, 2000
- Quality of life instruments in oncologyEuropean Journal Of Cancer, 1999
- A review of quality-of-life evaluations in prostate cancer.PharmacoEconomics, 1999
- Reporting on quality of life in randomised controlled trials: bibliographic studyBMJ, 1998
- The Problem of Quality of Life in MedicineJAMA, 1997
- Assessment of quality of life in clinical trialsStatistics in Medicine, 1991